Dr. Camille N. Abboud, MD

Dr. Abboud practices at Memorial Hospital in Belleville in Belleville, Illinois, part of BJC Health.

Dr. Abboud's NPI, 1316965320, was assigned on July 17, 2006. Dr. Abboud holds Missouri license 2006038044.

Dr. Abboud's primary practice is Memorial Hospital in Belleville, at 4500 Memorial Drive, Belleville, IL 62226 in St. Clair County. The practice phone is (618) 233-7750.

Dr. Abboud's primary practice is Memorial Hospital in Belleville in Belleville, Illinois, part of BJC Health. Dr. Abboud is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Abboud to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abboud practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Abboud's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Abboud is licensed in Missouri.

CMS data shows 350 Medicare services from Dr. Abboud across 3 procedure codes in 2024, for 158 Medicare patients. Medicare paid $27,355 for them. Every service was in an office.

CMS counts 158 Medicare patients who saw Dr. Abboud in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abboud's median patient age at 72, with 51% women.

In 2024, Dr. Abboud wrote 1,944 Medicare Part D claims for 189 patients. 63% of them were for generic drugs. CMS names the drug for 1,570 of them, across 39 drugs with 11 or more claims each, at $9,280,197 in total drug cost. In 2023, CMS named 1,644 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Abboud for performance year 2024, reported as part of a group. Dr. Abboud accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Abboud to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Hematologic Neoplasms and Hematologic Diseases. Open Payments lists research payments to Dr. Abboud that name 1 trial.

CMS Open Payments shows 215 general payments to Dr. Abboud from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Jazz Pharmaceuticals Inc. paid the most, $81,637. It also lists 11 research payments totaling $14,023 from 2018 to 2025, naming 1 clinical trial.